Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
Yi Sun, Jiaxuan Huang, Yufei Chen, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104172-104172
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Johannes Burtscher, Robert T. Mallet, Martin Burtscher, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101343-101343
Open Access | Times Cited: 207
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
Enrique Crisman, Pablo Duarte, E. Daudén, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 237-287
Open Access | Times Cited: 114
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Yawen Cai, Yuhui Chai, Yu Fu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 88
Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Cells (2021) Vol. 10, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 68
Walnut-Derived Peptide Activates PINK1 via the NRF2/KEAP1/HO-1 Pathway, Promotes Mitophagy, and Alleviates Learning and Memory Impairments in a Mice Model
Fanrui Zhao, Chunlei Liu, Li Fang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 9, pp. 2758-2772
Closed Access | Times Cited: 59
The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New Developments
Mohammad Rafi Khezri, Keyvan Yousefi, Ayda Esmaeili, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 1, pp. 177-191
Closed Access | Times Cited: 43
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
Yi Sun, Lijuan Xu, Dongpeng Zheng, et al.
Redox Biology (2023) Vol. 64, pp. 102793-102793
Open Access | Times Cited: 22
Impact of NQO1 dysregulation in CNS disorders
Yuhan Li, Maryam Khaleghi Ghadiri, Ali Gorji
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Cyclic Peptide Keap1–Nrf2 Protein–Protein Interaction Inhibitors: Design, Synthesis, and In Vivo Treatment of Acute Lung Injury
Jihua Zou, Jianyu Yan, Yifei Lü, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4889-4903
Closed Access | Times Cited: 8
Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway
Bingtian Xu, Jiangping Xu, Ningbo Cai, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 281-296
Closed Access | Times Cited: 65
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
Jakob S. Pallesen, Dilip Narayanan, Kim T. Tran, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4623-4661
Open Access | Times Cited: 44
Recent progress and applications of small molecule inhibitors of Keap1–Nrf2 axis for neurodegenerative diseases
Jing Wang, Yu Cao, Lu Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115998-115998
Closed Access | Times Cited: 17
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
An updated patent review of Nrf2 activators (2020-present)
Ziquan Zhao, Ruitian Dong, Keni Cui, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 1, pp. 29-49
Closed Access | Times Cited: 15
Remimazolam Suppresses Oxidative Stress and Apoptosis in Cerebral Ischemia/Reperfusion Injury by Regulating AKT/GSK-3β/NRF2 Pathway
Mingyue Duan, Ning Yu, Jia Liu, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 111-128
Open Access
Investigating the Interplay Between the Nrf2/Keap1/HO-1/SIRT-1 Pathway and the p75NTR/PI3K/Akt/MAPK Cascade in Neurological Disorders: Mechanistic Insights and Therapeutic Innovations
R Mukherjee, R.S. Rana, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Discovery of β-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1−nuclear factor erythroid 2-related factor 2 (Keap1−Nrf2) protein−protein interaction inhibitors for ulcerative colitis management
Ziquan Zhao, Hongjin Lu, Junjie Wang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117384-117384
Closed Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Structure-based molecular hybridization design and synthesis of Keap1-Nrf2 inhibitors for anti-inflammatory treatment
Xianan Qin, Ruilin Hou, Zhuo Qu, et al.
Bioorganic Chemistry (2025) Vol. 158, pp. 108350-108350
Closed Access
Design of Anti-depressant Phosphodiester Amino Acidic Keap1-Nrf2 Protein-Protein Interaction Inhibitors
Yi Sun, Jue Wang, Wanyu Ding, et al.
Redox Biology (2025), pp. 103620-103620
Open Access
Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
Le Zhang, Lijuan Xu, Haihu Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113599-113599
Closed Access | Times Cited: 29
Crystallography-Guided Optimizations of the Keap1–Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides
Guodong Liu, Ruilin Hou, Lijuan Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8289-8302
Closed Access | Times Cited: 20
Celastrol alleviates oxidative stress induced by multi-walled carbon nanotubes through the Keap1/Nrf2/HO-1 signaling pathway
Tao-Lin Qing, Lang Yan, Shaokang Wang, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 252, pp. 114623-114623
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top